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Summary 
The proficiency study for penicillins in porcine tissues was organized in accordance with ISO/IEC 
Guide 43-1 and 43-2 and ILAC-G13, and performed under accreditation.  
 
For this proficiency study, four test materials were prepared: 
• A blank porcine muscle material (M-A); 
• A porcine muscle material containing about 200 µg/kg cloxacilline and a trace of ampicillin (M-B); 
• A blank porcine kidney material (K-A); 
• A porcine kidney material containing about 100 µg/kg cloxacillin, 30 µg/kg ampicillin and about 20 
µg/kg penicillin G (K-B). 
During homogeneity testing, all materials proved to obtain sufficient homogeneity for proficiency 
testing.  
 
Forty-four laboratories were invited to participate in the proficiency study for penicillins in porcine 
tissues of which 21 laboratories, i.e. 48%, subscribed. Each laboratory received six randomly coded 
samples. The laboratories were asked to analyze the samples in duplicate according to their own 
laboratory procedures. It was mentioned that maintaining the stability of the samples (storage and pre-
treatment) was part of the proficiency test. 
 
Eighteen laboratories managed to submit results within the timeframe of the study of which 15 reported 
quantitative results for both the muscle and the kidney samples. Two laboratories reported only results 
for the muscle samples and one laboratory only reported screening results. The majority of the 
laboratories applied a validated and accredited method for the analyses.  
 
The stability of penicillins can, according to literature, be maintained by storing the samples below -70 
°C. Within this proficiency study a stability experiment at -20 °C was carried out. This stability study 
showed a degradation of ampicillin, cloxacillin and penicillin G above 75 % in the kidney material 
during the timeframe of the proficiency study. The penicillins in kidney proved to be instable even after 
stabilization by buffering the material at pH=6. Therefore, the kidney samples are not suited for 
evaluation purposes. 
During storage at -20 °C the muscle material showed a degradation of 31 % for ampicillin and 27% for 
cloxacillin was observed. However, the penicillins in the muscle material showed to be stable at -20 °C 
after buffering at pH=6. Therefore, the muscle materials are suitable for this proficiency study, because 
maintaining the stability was mentioned as a part of this proficiency study. 
 
In the stability study a degradation of penicillins during storage at -20 °C was observed, which is in 
agreement with literature. According to the information supplied by the participants, four laboratories 
stored their samples at -20 °C. Therefore it can be assumed that the samples of these laboratories were 
instable during the timeframe of the proficiency study. However, no statistically significant difference 
was observed between the results of the laboratories that stored the samples at -20 °C and the results of 
the laboratories that stored the samples at a temperature below -70 °C. Therefore, also the stability of 
the samples, even if stored at -70°C can be questioned. Probably, other factors than storage temperature 
are of influence on the stability. Based on these observations, the correctness of the calculated assigned 
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values (consensus values) can be questioned. Therefore, this proficiency study is evaluated for 
information only.  
 
The participants applied different methodologies for carrying out the analysis of penicillins in porcine 
tissues. Almost every laboratory applied identical procedures for muscle and kidney.  
The mainly applied extraction solvent is a phosphate buffer at pH 8 to 9, sometimes combined with an 
organic solvent. The majority of laboratories applied Solid Phase Extraction as a sample clean up 
technique. In all cases a C18 material or OASISTM HLB was used as stationary phase.  
Two laboratories applied a derivatization procedure. One laboratory applied a derivatization at the end 
of the sample clean up procedure using benzoic acid anhydride in combination with triazole and 
mercury chloride solution. The other laboratory applied a derivatization using piperidin during the 
extraction. 
 
For all compounds and materials a considerable variation of the reported results is observed, possibly 
caused by the instability of the materials. No relations were observed between the laboratories results 
and the storage temperature, storage time (date of analysis) or a combination of these factors.   
 
Based on the results, it is concluded that additional effort is needed to develop a robust method for the 
analysis of penicillins in porcine tissues. Stability of the compounds during storage seems to be an 
underestimated factor. Based on the results of the stability study, adequate storage and/or the use of a 
stabilization procedure at the time of arrival of the samples is required for obtaining reliable results.  
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1 Introduction 
1.1 Inter-laboratory testing 
Inter-laboratory testing is conducted to provide laboratories with a powerful tool to evaluate and 
demonstrate the reliability of the data that is produced. Next to validation and accreditation, inter-
laboratory testing is an important requirement of the EU Additional Measures Directive 93/99/EEC [1] 
and is increasingly important in the new ISO 17025:2005 [2].  
No internationally focused proficiency studies regarding the analysis of penicillins in porcine tissues 
were organized during the last years. Therefore an inter-laboratory quality control for this method was 
lacking. Therefore, RIKILT decided to organize a proficiency study regarding this subject. 
The aim of this proficiency study was to give laboratories the possibility to evaluate or demonstrate 
their competence for the analysis of penicillins in porcine muscle and kidney. Maintaining the stability 
of the provided samples was underlined as one of the important factors of this study. 
This study also provided an evaluation of the methods applied for quantitative and confirmatory 
analysis of penicillins.  
 
This proficiency study was conducted in accordance with guidelines ISO/IEC 43-1 [3], ISO/IEC 43-2 
[4] and ILAC-G13 [5] and was organized under accreditation by RIKILT - Institute of Food Safety. 
1.2 Penicillins 
The discovery of penicillins is attributed to Dr. Flemming in 1928 [6]. Penicillins are ß-lactam 
antibiotics used in the treatment of bacterial infections caused by Gram-positive organisms [7]. The 
narrow spectrum of activity of the penicillins, initiated the search for derivatives of penicillins which 
were able to treat a wider range of infections. Ampicillin, which offered a broader spectrum of activity 
than either of the original penicillins, was the first breakthrough. Later, ß-lactamase resistant (§1.3) 
penicillins like dicloxacillin were developed. 
 
Penicillins are widely used in swine, cattle and poultry to treat infections. Furthermore they are used as 
a feed additive in the prevention of diseases. Penicillins are rapidly cleared from the blood via the 
kidney into the urine. Therefore, the amount of penicillin residues in kidney is found to be much higher 
compared to muscle [8]. 
 
According to EU regulations, all substances for veterinary use need to be included in Annexes I, II or III 
of Council Regulation (EEC) No 2377/1990 [13], (EC) No 508/1999 [14]. Penicillins are included in 
Annex I: pharmacologically active veterinary products for which a Maximum Residue Limit (MRL) is 
established.  
 
This proficiency study focuses on ampicillin, cloxacillin and penicillin G (benzylpenicillin) in porcine 
muscle and kidney. For these penicillins the use and medication of swine is described [9-10]. The MRL 
for these compounds in porcine muscle and kidney is presented in Table 1.  
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Table 1. The MRL of penicillins in porcine tissues of penicillins included in the proficiency study [11-
12] 
Compound MRL in muscle (µg/kg) MRL in kidney (µg/kg) 
Ampicilline 50 50 
Cloxacillin 300 300 
Penicillin G 50 50 
         
 
          
           
 
 
 
 
Figure 1. Molecular structure of (a) ampicillin, (b) cloxacillin and (c) penicillin G 
1.3 Stability of penicillins 
The stability of penicillins in especially tissues is a main issue in the analysis of this compound group. 
Several studies pointed out that penicillins have limited stability at low and high pH. Maximum stability 
is obtained in the range of pH 6 to 7 [13-15]. pH is therefore an important factor in maintaining the 
stability of penicillins.  
Furthermore, the storage condition of tissue samples is an important factor in the stability. Several 
studies showed degradation of penicillins at a storage temperature of -20 °C. At approximately -75 °C 
the stability proved to be satisfactory. [16-18]. 
c 
a b 
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Already in 1940 an enzyme called penicillase, a ß-lactamase enzyme, was discovered that is able to 
break open the four-atom ß-lactam ring that is specific for penicillins [19]. Penicillase is formed by the 
bacteria E. coli and can be present in animal tissue. To prevent penicillins from degradation, most 
penicillins are administered in combination with a ß-lactamase inhibitor like clavulanic acid. Clavulanic 
acid contains a four-atom ß-lactam similar to penicillins. This results in a inhibition of the degradation 
of penicillins. In this way the penicillins can remain intact. 
Next to the pH, storage temperature and the presence of penicillase, the occurrence of the tissue is 
relevant regarding penicillin stability [18]. The use of ground muscle showed to result in more stability 
for penicillins compared to bulk or diced material. 
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2 Test materials 
2.1 Sample preparation 
Four fresh test materials were prepared containing different amounts of ampicillin (AMP), cloxacillin 
(CLOX) and penicillin G (PENG) by adding methanolic solutions of these compounds to blank porcine 
muscle and kidney according to table 2. The materials were homogenized under cryogenic conditions 
according to in-house standard operating procedures. 
 
Table 2.Target amount of penicillins in the proficiency study test materials  
Material code Matrix Target amount of 
AMP 
Target amount of 
CLOX 
Target amount of 
PENG 
Amount of material 
(g) 
M-A Porcine muscle - - - 1500 
M-B Porcine muscle ca. 0.1*MRL   ca. MRL - 3000 
K-A Porcine kidney - - - 1300 
K-B Porcine kidney ca. MRL ca. 0.5*MRL ca. 0.5*MRL 2600 
2.2 Sample identification 
Materials M-A, M-B, K-A and K-B were stored in polypropylene containers containing at least 30 gram 
of matrix, yielding a total of 42 containers of material M-A and K-A, and 79 containers of material M-B 
and K-B. The muscle samples were randomly coded with a code from M/2006/001 through 
M/2006/121. The kidney samples were randomly coded with a code from K/2006/001 through 
K/2006/121.  
For homogeneity and stability testing, 12 randomly chosen containers of material M-A and K-A, and 19 
randomly chosen containers of material M-B and K-B were used.  
For each laboratory a sample set was at randomly prepared consisting of one sample of material M-A 
and K-A, and two samples of material M-B and K-B.  The sample numbers belonging to each sample 
set are presented in Annex 1. 
2.3 Homogeneity study 
Ten containers of materials M-B and K-B were each analyzed in duplicate for ampicillin, cloxacillin and 
penicillin to determine the homogeneity of the materials. The homogeneity study was carried out 
according to The International Harmonized Protocol for Proficiency Testing of Analytical Laboratories 
[20] and ISO/DIS 13528 [21], taking into account the insights discussed by Fearn et al. [22] and 
Thompson [23]. 
The results of the homogeneity study and their statistical evaluation is presented in Annex 2a through e. 
All materials were demonstrated to be sufficiently homogeneous for use in the proficiency study. During 
the homogeneity study the amount of all penicillins in both materials M-B and K-B proved to be lower 
than expected. Nevertheless, the determined levels were relevant and the samples were found suitable 
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for application in the proficiency study. The amounts determined during the homogeneity study are 
presented in table 3. 
The at random chosen samples of material M-A and K-A were analyzed for seven penicillins. No 
amoxycillin, ampicillin, cloxacillin, dicloxacillin, oxacillin, penicillin G and phenoxymethylpenicillin 
(penicillin V) were detected in the materials M-A and K-A (< 5 µg/kg). It was concluded that materials 
M-A and K-A are suited for use as blank materials in the proficiency study. 
 
Table 3. Determined amount of penicillins in the proficiency study test materials  
Material code Matrix Target amount of 
AMP (µg/kg) 
Target amount of 
CLOX (µg/kg) 
Target amount of 
PENG (µg/kg) 
M-A Porcine muscle - - - 
M-B Porcine muscle Trace (< 10) 192 - 
K-A Porcine kidney - - - 
K-B Porcine kidney 32 116 22 
2.4 Participants 
Forty-four laboratories were invited to participate in the proficiency study for penicillins in porcine 
tissues. These were mainly European laboratories, but also several inter-continental laboratories were 
invited. Twenty-one laboratories, i.e. 48%, subscribed for participation.  
2.5 Sample distribution 
Each of the participating laboratories received a randomly assigned laboratory code (001 through 021). 
The sample sets with the corresponding number, consisting of six coded samples, were sent to the 
participating laboratory at the 12th of December. The sample sets were packed in an insulating box, 
containing dry ice and were dispatched to the participants immediately by courier. Due to customs 
regulations the samples did not arrive at one of the laboratories (001). This laboratory was therefore not 
able to participate. One laboratory (017) reported that the samples were cold but partially thawed at 
arrival. In agreement with this laboratory, it was decided not to send a new sample set. All other 
laboratories confirmed the receipt of the samples in good condition (frozen). 
 
The samples were accompanied by a letter describing the requested analyses, an acknowledgement of 
receipt form and a results form. Furthermore, a reference standard of ampicillin, including a certificate 
of analysis, was included in the packages. The participants were asked to use this reference standard in 
their analysis. With this, the influence of the reference standard on the deviation of laboratory results 
can be determined during the evaluation process. 
 
The laboratories were informed that maintaining the stability of the samples was part of the proficiency 
study. Furthermore, the laboratories were advised to store the samples at < -70 °C until analysis. A 
duplicate analysis of each sample was requested, resulting in two results for materials M-A and K-A, 
and four results for material M-B and K-B. The deadline for sending in results was the 31st of January, 
allowing the participants at least six weeks for analysis.  
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2.6 Stability 
After preparation of the samples nine samples of each material were at randomly picked for use in the 
stability study. Each of these samples was split in two aliquots. The first aliquots were stabilized 
(addition of phosphate buffer pH=6) whilst the second aliquots did not undergo any further treatment. 
Two samples of each material (both with and without stabilization) were stored at -80°C directly after 
preparation (t=0). The other samples were stored at -20 °C. In this experiment the samples are assumed 
to be stable at a storage temperature of -80 °C. 
 
On the 7th of February, just after the deadline of the proficiency study, two samples of each material 
stored at -20 °C (both with and without stabilization) were analyzed together with the samples stored at 
-80 °C. For each point in time the average of the results was calculated.  
The results of both storage conditions were compared using a Student's t-test [24]. The hypothesis for 
this test is: 
 
)0 -80 -20H : E(x )= E(x  
  
where:   
)-80E(x = expected average of the samples stored at -80 °C;   
)-20E(x = expected average of the samples stored at -20 °C. 
 
The standard deviation of both analyses are considered the same, because the same analytical procedure 
is applied to obtain the results. Therefore the value t is calculated by: 
 
-80 -20
-80 -20
x - x
t =
1 1
s +
n n
 
  
where: 
-80x = the average amount calculated for the samples stored at -80 °; 
-20x = the average amount calculated for the samples stored at -20 °C; 
-80n = number of samples stored at -80 °C; 
-20n = number of samples stored at -20 °C; 
 
2 2
-80 -20
p
-80 -20
(n - 1)s +(n - 1)s
s =
(n + n - 2)
 
 
where: 
ps  = pooled standard deviation; 
-80n = number of samples stored at -80 °C; 
-20n = number of samples stored at -20 °C; 
s = standard deviation of the analyses calculated from the CV% resulting from the validation procedure. 
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The calculated value t is compared to a critical value ( critt ) derived from a Students-t table using a 
confidence level of 95% with t having -80 -20n + n - 2 degrees of freedom [17]. If t < tcrit it is demonstrated 
that no statistically significant degradation of the penicillins during storage at -20 °C occurs.  
 
The results and evaluation of the stability test are presented in Appendix 3a through e.  
It is demonstrated that a tremendous loss of ampicillin, cloxacillin and penicillin G in kidney occurs. 
The loss of these penicillins in the samples that did not undergo any treatment was at least 75%. The 
loss of these penicillins in the samples that were stabilized by addition of phosphate buffer pH=6 
differed from 21% for cloxacillin to 47% for ampicillin. It is concluded that the penicillins in kidney 
degrade during storage at -20 °C. Adjustment of the pH to 6 can slow down the degradation, but will not 
stop it. 
Also for the muscle samples that did not undergo any treatment a severe loss of both ampicillin and 
cloxacillin was observed. The degradation of ampicillin and cloxacillin in muscle was significantly 
lower compared to the kidney samples: ampicillin decreases with 31% and the loss of cloxacillin was 
27%. For ampicillin the degradation is statistically significant according to the Students-t test. 
According to the calculation the degradation of cloxacillin is not statistically significant. This is caused 
by the low amount of degrees of freedom which results in a high critical value ( critt ). Nevertheless, a 
degradation of 27 % is considered as a significant difference. It is concluded that ampicillin as well as 
cloxacillin degraded in the porcine muscle material during the timeframe of the proficiency study if 
stored at -20 °C. 
For the muscle samples that are stabilized by addition of phosphate buffer pH=6, no significant loss is 
observed during the period of storage. 
 
This experiment demonstrates the instability of penicillins in mainly the porcine kidney material but 
also in the muscle material at a storage temperature of -20 °C. The necessity to store the compounds at a 
temperature below 70 °C and/or to apply a procedure to stabilize the compounds is demonstrated by the 
present study. 
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3 Applied methodologies 
The participating laboratories applied different sample preparation procedures for the analysis of 
penicillins in porcine tissues. Almost every laboratory applied identical procedures for muscle and 
kidney. A schematic overview of the methods applied is presented in Annex 4. 
 
Fourteen of the eighteen laboratories stored the samples at -90 to -70 °C before analysis. Four 
laboratories stored the samples at approximately -20 °C. Only one laboratory (015) applied a 
stabilization procedure by buffering the sample at pH=6 at arrival. 
 
Eight laboratories used a phosphate buffer at pH 8-9 as the extraction solvent, sometimes combined with 
an organic solvent. The other laboratories applied water, methanol, acetonitrile, petroleum ether and 
mixtures of those solvents for the extraction. In all cases the pH of the solvent was neutral or slightly 
basic. This is in agreement with literature regarding stability of penicillins in solution (§1.3). 
 
Thirteen laboratories applied solid phase extraction as a sample clean up technique. In all cases a C18 
material or OASISTM HLB was used as stationary phase, either silica bound or on polymeric basis. Four 
laboratories (009, 010, 011 and 016) only evaporated the extraction solvent, in some cases followed by 
(ultra)filtration. 
 
Two laboratories applied a derivatization procedure. One laboratory (005) applied a derivatization at the 
end of the sample clean up procedure using benzoic acid anhydride in combination with triazole and 
mercury chloride solution. The other laboratory (015) applied a derivatization using piperidine during 
the extraction. 
 
Two detection techniques are applied for the quantitative analysis of penicillins in porcine tissues. 
Fifteen laboratories applied LC-MS/MS as a detection technique according to 2002/657/EC [25] 
regarding criteria for confirmation of the identity. One laboratory (005) applied LC-DAD as a detection 
technique. 
 
Of the participants that used LC-MS/MS as a detection technique, nine used one or more internal 
standards for the quantification of the penicillins. The internal standards used are: 
• 13C2-penicillin G and d10-piperidinepenicillins, the only deuterated standard used 
• Penicillin V, after a screening procedure or in case penicillin V is not included in the method 
• Sulfamethazin 
• Methicillin 
• Nafcillin 
 
The laboratories that did not analyze for one or more of the penicillins mentioned in the invitation letter 
are presented in Table 4. It is noted that amoxycillin, cloxacillin, dicloxacillin, oxacillin and especially 
phenoxymethylpenycillin are not included by all laboratories. These compounds however, are registered 
for medication in swine within the EU and a MRL for swine tissues is established. Therefore, these 
compounds should be included in a method of analysis used in the framework of EU regulatory control 
of residues in porcine tissues.  
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Table 4. Overview of laboratories that did not include all quinolones in the analysis. 
Compound Not included by lab 
Amoxycillin 17 
Ampicillin  
Cloxacillin 21 
Dicloxacillin 21 
Oxacillin 17, 21 
Penicillin G  
Phenoxymethylpenicillin  10, 19, 21 
 
An overview of the method performance characteristics of the participating laboratories is presented in 
Annex 5. All values are presented as reported by the laboratories without any adjustments. Eight of the 
17 participating laboratories (i.e. 47%) applied a validated method whilst three laboratories reported that 
their validation was on going. Eleven of the participating laboratories (i.e. 65%) laboratories reported to 
have their method accredited. It was noticed that 65% of the participating laboratories reported that their 
method is accreditated whilst only 47% of these laboratories carried out a validation study. Probably 
some laboratories interpreted the question about validation and accreditation differently. 
 
Amongst the participating laboratories, five laboratories (005, 008, 011, 015, 019) did report values for 
CCα. Hence, the minority of participating laboratories is already able to report their results as required 
by Commission Decision 2002/657/EC [25] coming in force from the 1st of August 2007. 
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4 Statistical evaluation 
The statistical evaluation was carried out according to the International Harmonized Protocol for the 
Proficiency Testing of Analytical Laboratories [20], elaborated by ISO, IUPAC and AOAC and ISO/DIS 
13528 [21] in combination with the insights published by the Analytical Methods Committee [26, 27] 
regarding robust statistics. 
 
4.1 Calculation of the assigned value 
The assigned value (X) was determined using robust statistics [26-28]. The advantage of robust statistics 
is that all values are taken into account: outlying observations are retained, but given less weight. 
Furthermore, it is not expected to receive normally distributed data in an inter-laboratory proficiency 
test. When using robust statistics, the data does not have to be normally distributed in contrast to 
conventional outlier elimination methods. 
The robust mean of the reported results of all participants was used as the assigned value. The assigned 
value is therefore a consensus value. 
4.2 Calculation of the uncertainty of the assigned value 
The uncertainty of the assigned value is calculated to determine the influence of this uncertainty on the 
evaluation. A high uncertainty of the assigned value will lead to a high uncertainty of the calculated 
participants za-scores. If the uncertainty of the assigned value and thus the uncertainty of the za-score is 
high, the evaluation could indicate unsatisfactory method performance without any cause within the 
laboratory. 
In other words, is it legitimate to draw any conclusion regarding the performance of the participating 
laboratories from the calculated assigned value and za-scores? 
The uncertainty of the assigned value (the robust mean) is calculated from the estimate of the standard 
deviation of the assigned value and the number of values used for the calculation of the assigned value: 
 
σˆ
u =
n
 
where: 
u = uncertainty of the assigned value;  
n = number of values used to calculate the assigned value;  
σˆ= The estimate of the standard deviation of the assigned value resulting from robust statistics. 
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According to ISO/DIS 13528 [21] the uncertainty of the assigned value (u) is negligible and therefore 
does not have to be included in the statistical evaluation if: 
 
u≤ p0.3σ  
 
where: 
u = The uncertainty of the assigned value; 
pσ = target standard deviation (§ 4.3). 
 
In case the uncertainty of the assigned value does not comply with this criterion, the uncertainty of the 
assigned value should be taken into account when evaluating the performance of the participants 
regarding the accuracy (§ 4.4). 
4.3 Calculation of the target standard deviation 
According to Commission Decision 2002/657/EC [25], the inter-laboratory coefficient of variation for 
the repeated analysis of a reference or fortified material, under reproducibility conditions, shall not 
exceed the level calculated by the Horwitz equation. 
The Horwitz equation, 0.8495Hσ = 0.02c presents a useful and widespread applied relation between the 
expected standard deviation under reproducibility conditions, Hσ and the concentration, c. It expresses 
inter-laboratory precision expected in inter-laboratory trials. Therefore, this relation is suitable for 
calculating the target standard deviation, pσ in inter-laboratory trials. 
Thompson [23] demonstrated that the Horwitz equation is not applicable to the lower concentration 
range (<120 µg/kg) as well as to the higher concentration range (>138 g/kg). Therefore a 
complementary model is suggested: 
 
For analyte concentrations <120 µg/kg: 
Hσ = 0.22c      
 
For analyte concentrations >138 g/kg: 
0.5
Hσ = 0.01c  
  
where: 
Hσ = expected standard deviation in inter-laboratory trials; 
c = concentration of the analyte. 
  
The target standard deviation, pσ , was determined using the equation for analyte concentrations <120 
µg/kg for ampicillin in muscle and for ampicillin, cloxacillin and penicillin G in kidney. The Horwitz 
equation was used for determining the target standard deviation, pσ , for cloxacillin in muscle.  In these 
calculations c = the assigned value (X) and H pσ = σ . 
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4.4 Performance characteristics with regard to the accuracy 
For illustrating the performance of the participating laboratories with regard to the accuracy a za-score is 
calculated. For the evaluation of the performance of the laboratories, the Guidelines of ISO/IEC Guide 
43-1 [3] and ISO/DIS 13528 [21] are applied. According to these guidelines za-scores are classified as 
presented in Table 5.  
 
Table 5: Classification of z-scores 
z ≤ 2 satisfactory 
2 < z < 3 questionable 
z ≥ 3 unsatisfactory 
 
 
If the calculated uncertainty of the assigned value complies with the criterion mentioned in § 4.2, the 
uncertainty is negligible. In this case the accuracy z-score is calculated from: 
 
a
p
x - X
z =
σ
 
 
where: 
az = accuracy z-score; 
x = the average result of the laboratory; 
X = assigned value; 
pσ = target standard deviation. 
 
However, if the uncertainty of the assigned value does not comply with the criterion mentioned in § 4.2, 
it could influence the evaluation of the laboratories. Therefore this uncertainty is taken into account by 
calculating the accuracy z-score [11]: 
 
'
a 2 2
p
x - X
z =
σ +u
 
  
where: 
'
az = accuracy z-score taking into account the uncertainty of the assigned value; 
x = mean result of the laboratory; 
X = assigned value; 
pσ = target standard deviation; 
u = uncertainty of the assigned value. 
4.5 Performance characteristics with regard to reproducibility  
In addition to the evaluation of the accuracy, it is useful to inform the participants about the 
reproducibility of the results. In the design of this inter-laboratory study, two blind samples of material 
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M-B and K-B were submitted to the participants. Therefore, every laboratory reported multiple results 
for these materials. From the results of the blind samples of material M-B and K-B the repeatability ( rs ) 
and an estimate of the within-lab-reproducibility (
LR
s ) were calculated [28]. 
 
The repeatability standard deviation is calculated from: 
 
2
id
rs = 2p
  
 
where: 
rs = repeatability standard deviation; 
id = difference between the individual values for a pair; 
p = number of pairs. 
 
An estimate of the within-lab-reproducibility standard deviation is calculated from: 
 
2L
2
R L r
s = s + s  
  
where: 
LR
s = estimate of the within-lab-reproducibility standard deviation; 
rs = repeatability standard deviation; 
 
2 2 2
p p r
L
p (x ) - ( x ) s
s = -
p(p - 1) 2
  
 
where: 
Ls = between sample variance (if Ls <0 this value is assumed to be zero) 
 p = number of pairs; 
px = average result of the duplicates; 
rs = repeatability standard deviation. 
 
Because the samples are not analyzed under true within-lab reproducibility conditions, the estimate of 
the within-lab reproducibility standard deviation (
LR
s ) will always be lower than the true within-lab 
reproducibility standard deviation.  
To inform a laboratory of its performance for reproducibility, the Horwitz-ratio (HORRAT) is a suitable 
value [29]. In this report, the HORRAT is calculated from the estimate of the within-lab reproducibility, 
because it is not possible to calculate a reproducibility standard deviation from the laboratory data. The 
reproducibility standard deviation ( Rs ) includes inter-laboratory variation and must therefore always be 
higher than the estimate of the within-lab reproducibility (
LR
s ).  
Because the HORRAT value is calculated from 
LR
s  instead of Rs , this value is not for evaluation 
purposes but for information only.  
 
∑ 
∑ ∑ 
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The HORRAT is calculated from: 
 
LR
p
s
HORRAT =
σ
  
 
where: 
HORRAT  = Horwitz ratio; 
LR
s = estimate of the within-lab reproducibility standard deviation; 
pσ = target standard deviation (§ 4.3). 
 
In this formula, a HORRAT value equal to 1.0 indicates that the estimate of the within-lab 
reproducibility is equal to the predicted maximum reproducibility standard deviation resulting from the 
Horwitz equation. However, the latter refers to reproducibility between laboratories and, hence, would 
normally be higher than the within-lab reproducibility. Therefore it is within reason that the HORRAT 
value calculated from the estimate of the within-lab reproducibility, as done in this report, should be 
substantially below 1.0.  
Nonetheless in this report, a HORRAT value is not regarded as a questionable result unless it exceeds 
1.0. 
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5 Results and discussion 
Twenty-one out of 44 (i.e. 47%) invited laboratories subscribed for the participation in the inter-
laboratory study for penicillins in porcine tissues. Due to customs regulations, it was not possible to ship 
the samples to one of the laboratories (001). Therefore, this laboratory was not able to participate. 
Eighteen laboratories (i.e. 90 %) managed to submit valid results before the deadline of the 31st of 
January. Laboratory 14 carried out a screening analysis only. Therefore this laboratory is not included in 
the quantitative evaluation. 
 
Because of the noticed instability at -20 °C of ampicillin, cloxacillin and penicillin G in the kidney 
material and ampicillin in the muscle material, for these compounds only the assigned value is 
calculated. The data of cloxacillin in the muscle material is more extensively evaluated (§5.1). The 
laboratories results and the calculated assigned value are presented in Annex 6a for ampicillin in 
muscle, 6b for cloxacillin in muscle, 6c for ampicillin in kidney, 6d for cloxacillin in kidney and 6e for 
penicillin G in kidney. 
 
None of the laboratories detected any penicillins in the blank materials (material M-A and K-A). No 
false positive results occurred. 
5.1 Evaluation of the results of cloxacillin in muscle 
Three laboratories that sent in results did not report quantitative results for cloxacillin in material M-B. 
Therefore the evaluation of cloxacillin in muscle is based on the results of 15 laboratories. The 
laboratory results as well as the statistical evaluation of cloxacillin in the muscle material are presented 
in Annex 6b. 
 
Of the laboratories that reported quantitative results for cloxacillin in the muscle material, four 
laboratories stored the samples at approximately -20 °C before analysis and eleven laboratories stored 
the samples at temperatures below -70 °C. In the stability study a small degradation (27%) of cloxacillin 
in the muscle material was observed at -20 °C. In literature [16-18] it is reported that penicillins are 
stable at storage temperatures below -70 °C. Therefore a difference in the laboratory results of 
laboratories that stored the samples at -20 °C versus the laboratory results of the laboratories that stored 
the samples below -70 °C is expected.  
The effect of the storage temperature of the samples on the reported results was explored. An overview 
of the storage temperature versus the laboratories average result for cloxacillin in muscle is presented in 
annex 7. No statistically significant relation is found between these two parameters. This is in 
disagreement with the expectations, literature [16-18] and the stability study. Probably more factors 
have influence on the stability like storage time, presence of enzymes and the amount of defrosting 
cycles. 
 
One laboratory (004) analyzed the samples within one week after shipment of the samples (19th of 
December). The other laboratories analyzed the samples between the 4th and the 31st of January (i.e. at 
least three weeks after shipment). Laboratory 004 reports the highest average result which may indicate 
a relation between the storage time and the laboratories results. Therefore, the effect of the storage time 
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on the laboratories results was explored. An overview of the date of analysis versus the reported results 
is presented in Annex 8. Unfortunately, only one laboratory analyzed the samples in December. This 
results in only one data point for the first three weeks after shipment of the samples. Therefore, no 
statistical conclusions can be drawn from the data regarding the effect of the storage time on the 
laboratories results. 
 
Also the combination of the storage time and the storage temperature could be of influence on the 
results. Therefore, both factors were combined in several ways to find out if any relation between the 
combination of these factors and the reported results could be found. None of these combinations 
resulted in a clear relation with the reported results.  
 
For material M-B the lowest value reported is 72.6 µg/kg and the highest value is 390 µg/kg. The 
assigned value of cloxacillin in material M-B, the consensus value resulting from the robust statistics, is 
135 µg/kg with an uncertainty of 9.5 µg/kg. The target standard deviation, pσ , is 29.2 µg/kg. The 
uncertainty of the assigned value of cloxacillin in material M-B exceeds 0.3 pσ  (§4.2). Therefore, for 
this material, the uncertainty of the assigned value is taken into account in the evaluation of the 
laboratories; za'-scores are calculated. The za’-scores and HORRAT values for cloxacillin obtained by 
each laboratory were calculated. The results are presented in Annex 6b. A graphical representation of the 
za’-scores and HORRAT values is included. 
 
The results of the participating laboratories are not in agreement with the expectations based on the 
storage conditions applied by the laboratories. It is observed that the two laboratories that obtained 
'questionable' results (004, 013) both reported results above the assigned value. This could indicate 
better stability at these laboratories. Therefore, the correctness of the assigned value, which is a 
consensus value of all laboratory results, can be questioned. 
 
Based on these observations, no conclusions regarding the performance of the laboratories can be drawn 
from this evaluation. Figures are given for information only, not for evaluation of the participating 
laboratories.  
 RIKILT Report 2007.007 21
6 Conclusions 
Forty-four laboratories were invited to participate in the inter-laboratory study for penicillins in porcine 
tissues, of which 21 laboratories subscribed. Eighteen laboratories reported their results within the given 
timeframe. Two laboratories reported results for the muscle samples only and one laboratory only 
reported screening results. The majority of the laboratories applied a validated and accredited method 
for the analysis of penicillins in porcine tissues. 
 
For this proficiency test, four test materials were prepared: two porcine muscle samples containing 
ampicillin and cloxacillin and two porcine kidney samples containing ampicillin, cloxacillin and 
penicillin G. During homogeneity testing, all materials proved to obtain sufficient homogeneity for 
proficiency testing.  
 
The stability of penicillins can, according to literature, be maintained by storing the samples below -70 
°C. Within this proficiency study a stability study at -20 °C was carried out. This stability study showed 
a severe degradation of ampicillin, cloxacillin and penicillin G in the kidney material during the 
timeframe of the proficiency study. Even after stabilization by buffering the material at pH=6, the 
penicillins in kidney proved to be instable. Therefore, the kidney samples are not suited for evaluation 
purposes. 
In the muscle material a degradation of 31 % for ampicillin and 27% for cloxacillin was observed. 
However, after buffering the muscle material at pH=6 the penicillins showed to be stable at -20 °C  
Because maintaining stability was mentioned as a part of this proficiency study, the muscle materials are 
suitable for this proficiency test.  
 
According to the information supplied by the participants, four laboratories stored their samples at -20 
°C. These laboratories did not apply a specific treatment for stabilization. Therefore it can be assumed 
that the samples of these laboratories were instable during the timeframe of the proficiency study. 
However, no statistically significant difference was observed between the results of the laboratories that 
stored the samples at -20 °C and the results of the laboratories that stored the samples at a temperature 
below -70 °C. Therefore, also the stability of the samples, even if stored at -70°C can be questioned. 
Probably, other factors than storage temperature are of influence on the stability. Based on these 
observations, the correctness of calculated assigned values, which are a consensus values, can be 
questioned. Therefore, this proficiency study is evaluated for information only.  
 
For all compounds and materials a considerable variation of the reported results is observed, probably 
caused by the instability of the materials. No statistical relation was observed between the results and 
the storage temperature, storage time (date of analysis) or a combination of these factors.   
 
Amongst the participating laboratories, five laboratories (005, 008, 011, 015, 019) reported values for 
CCα. Hence, the minority of participating laboratories is able to report their results as required by 
Commission Decision 2002/657/EC [25] from the 1st of August 2007. Therefore extra effort is needed 
regarding the validation of the applied methods for the analysis of penicillins in porcine tissues. 
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Based on the results, it is concluded that extra effort is needed regarding the analysis of penicillins in 
porcine tissues. Stability of the compounds seems to be an underestimated factor. It is concluded that 
extra effort is needed to obtain more information regarding the stability of penicillin in porcine tissues. 
Next to this, it is recommended to each laboratory to include stability testing of penicillins in porcine 
tissues in the validation procedure. 
 
Furthermore, it is concluded that the organization of a proficiency study for penicillin analysis in 
tissues, working with fresh materials is complex. To be able to guarantee stability of the penicillin 
compounds during storage at each of the participating laboratories stringent guidelines for storage and 
pretreatment of the samples is necessary. 
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Annex 1 Codification of the samples 
 
 
Sample set Material M-A Material M-B Material K-A Material K-B 
1 M/2006/014 M/2006/020 K/2006/007 K/2006/021 
  M/2006/099  K/2006/055 
2 M/2006/077 M/2006/107 K/2006/115 K/2006/064 
  M/2006/061  K/2006/071 
3 M/2006/060 M/2006/062 K/2006/111 K/2006/062 
  M/2006/047  K/2006/088 
4 M/2006/053 M/2006/003 K/2006/027 K/2006/041 
  M/2006/104  K/2006/052 
5 M/2006/042 M/2006/118 K/2006/024 K/2006/025 
  M/2006/038  K/2006/001 
6 M/2006/068 M/2006/058 K/2006/012 K/2006/018 
  M/2006/064  K/2006/040 
7 M/2006/051 M/2006/033 K/2006/099 K/2006/118 
  M/2006/008  K/2006/120 
8 M/2006/041 M/2006/109 K/2006/110 K/2006/106 
  M/2006/100  K/2006/028 
9 M/2006/106 M/2006/056 K/2006/054 K/2006/107 
  M/2006/111  K/2006/068 
10 M/2006/094 M/2006/036 K/2006/029 K/2006/013 
  M/2006/039  K/2006/049 
11 M/2006/089 M/2006/044 K/2006/117 K/2006/082 
  M/2006/087  K/2006/009 
12 M/2006/088 M/2006/019 K/2006/035 K/2006/087 
  M/2006/091  K/2006/092 
13 M/2006/016 M/2006/067 K/2006/095 K/2006/097 
  M/2006/085  K/2006/048 
14 M/2006/012 M/2006/079 K/2006/103 K/2006/079 
  M/2006/066  K/2006/096 
15 M/2006/032 M/2006/046 K/2006/014 K/2006/069 
  M/2006/022  K/2006/080 
16 M/2006/049 M/2006/070 K/2006/046 K/2006/008 
  M/2006/120  K/2006/085 
17 M/2006/002 M/2006/054 K/2006/036 K/2006/086 
  M/2006/092  K/2006/047 
18 M/2006/050 M/2006/017 K/2006/015 K/2006/077 
  M/2006/084  K/2006/003 
19 M/2006/098 M/2006/018 K/2006/075 K/2006/020 
  M/2006/103  K/2006/017 
20 M/2006/011 M/2006/021 K/2006/104 K/2006/005 
  M/2006/083  K/2006/108 
21 M/2006/013 M/2006/001 K/2006/066 K/2006/011 
  M/2006/040  K/2006/109 
 
 RIKILT Report 2007.007 27
Annex 2a Statistical evaluation of homogeneity data of material M-B for 
ampicillin 
 
 
 Ampicillin (µg/kg) 
Sample No. Replicate 1 Replicate 2 
1 6.2 7.1 
2 6.7 5.9 
3 9.1 7.5 
4 5.9 8.1 
5 5.6 6.5 
6 6.7 6.4 
7 6.6 6.0 
8 4.9 6.6 
9 5.9 6.7 
10 6.8 6.0 
Grand mean 6.6 
Cochran’s test   
C 0.339 
Ccrit 0.602 
C < Ccrit? NO OUTLIERS 
Target sd (σp) Horwitz: 1.44 
san 0.845 
ssam 0.359 
σall 0.432 
critical 1.074 
ssam
2 < critical? ACCEPTED 
 
No amoxicillin, dicloxacillin, penicillin G, oxacillin and phenoxymethylpenicillin were detected in the 
samples (< 0.1 MRL µg/kg).  
 
san = estimate of analytical variance 
ssam = estimate of sampling variance 
σall = allowable sampling variance 
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Annex 2b Statistical evaluation of homogeneity data of material M-B for 
cloxacillin 
 
 
 Cloxacillin (µg/kg) 
Sample No. Replicate 1 Replicate 2 
1 182 188 
2 181 180 
3 198 232 
4 180 177 
5 192 200 
6 216 199 
7 218 186 
8 200 177 
9 192 190 
10 184 171 
Grand mean 192 
Cochran’s test   
C 0.352 
Ccrit 0.602 
C < Ccrit? NO OUTLIERS 
Target sd (σp) Horwitz: 39.4 
san 12.8 
ssam 9.02 
σall 11.8 
critical 428 
ssam
2 < critical? ACCEPTED 
 
No amoxicillin, dicloxacillin, penicillin G, oxacillin and phenoxymethylpenicillin were detected in the 
samples (< 0.1 MRL µg/kg).  
 
san = estimate of analytical variance 
ssam = estimate of sampling variance 
σall = allowable sampling variance 
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Annex 2c Statistical evaluation of homogeneity data of material K-B for 
ampicillin 
 
 
 Ampicillin (µg/kg) 
Sample No. Replicate 1 Replicate 2 
1 33.8 31.1 
2 30.7 31.3 
3 33.9 29.4 
4 29.4 30.6 
5 32.0 31.2 
6 33.4 31.5 
7 31.7 33.8 
8 32.1 29.9 
9 32.1 32.2 
10 37.1 31.5 
Grand mean 31.9 
Cochran’s test   
C 0.423 
Ccrit 0.602 
C < Ccrit? NO OUTLIERS 
Target sd (σp) Horwitz: 7.03 
san 1.926 
ssam 0.00 
σall 4.44 
critical 2.11 
ssam
2 < critical? ACCEPTED 
 
No amoxicillin, dicloxacillin, oxacillin and phenoxymethylpenicillin were detected in the samples (< 0.1 
MRL µg/kg).  
 
san = estimate of analytical variance 
ssam = estimate of sampling variance 
σall = allowable sampling variance 
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 Annex 2d Statistical evaluation of homogeneity data of material K-B for 
cloxacillin 
 
 
 Cloxacillin (µg/kg) 
Sample No. Replicate 1 Replicate 2 
1 109 112 
2 117 115 
3 120 114 
4 108 108 
5 118 117 
6 121 117 
7 119 116 
8 118 115 
9 122 117 
10 116 111 
Grand mean 116 
Cochran’s test   
C 0.269 
Ccrit 0.602 
C < Ccrit? NO OUTLIERS 
Target sd (σp) Horwitz: 25.4 
san 2.59 
ssam 3.25 
σall 7.62 
critical 116 
ssam
2 < critical? ACCEPTED 
 
No amoxicillin, dicloxacillin, oxacillin and phenoxymethylpenicillin were detected in the samples (< 0.1 
MRL µg/kg).  
 
san = estimate of analytical variance 
ssam = estimate of sampling variance 
σall = allowable sampling variance 
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Annex 2e Statistical evaluation of homogeneity data of material K-B for 
penicillin G 
 
 
 Penicillin G (µg/kg) 
Sample No. Replicate 1 Replicate 2 
1 21.5 21.5 
2 21.5 21.5 
3 22.6 21.7 
4 21.6 20.6 
5 22.3 23.5 
6 20.8 21.4 
7 22.1 23.0 
8 22.7 23.0 
9 22.5 23.6 
10 21.7 22.3 
Grand mean 22.1 
Cochran’s test   
C 0.237 
Ccrit 0.602 
C < Ccrit? NO OUTLIERS 
Target sd (σp) Horwitz: 4.86 
san 0.55 
ssam 0.64 
σall 1.46 
critical 4.30 
ssam
2 < critical? ACCEPTED 
 
No amoxicillin, dicloxacillin, oxacillin and phenoxymethylpenicillin were detected in the samples (< 0.1 
MRL µg/kg).  
 
san2 = estimate of analytical variance 
ssam2 = estimate of sampling variance 
σall2 = allowable sampling variance 
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Annex 3a Statistical evaluation of stability data of material M-B for 
ampicillin  
 
 
Statistical evaluation for ampicillin in material M-B without treatment 
Date of storage 
at -80 °C 
Time at -20°C 
(days) 
Average amount  
(µg/kg) 
n Pooled st. dev 
(µg/kg) 
t tcrit t < tcrit 
Nov 23, 2006 0 3.9 2     
Feb 07, 2007 76 2.7 2 0.22 5.4 4.3 NOT ACCEPTED 
 
 
Statistical evaluation for ampicillin in material M-B after adjustment to pH=6 
Date of storage 
at -80 °C 
Time at -20°C 
(days) 
Average amount  
(µg/kg) 
n Pooled st. dev 
(µg/kg) 
t tcrit t < tcrit 
Nov 23, 2006 0 4.5 2     
Feb 07, 2007 76 5.0 2 0.31 1.6 4.3 ACCEPTED 
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Annex 3b Statistical evaluation of stability data of material M-B for 
cloxacillin  
 
 
Statistical evaluation for cloxacillin in material M-B without treatment 
Date of storage 
at -80 °C 
Time at -20°C 
(days) 
Average amount  
(µg/kg) 
n Pooled st. dev 
(µg/kg) 
t tcrit t < tcrit 
Nov 23, 2006 0 143 2     
Feb 07, 2007 76 105 2 8.9 4.2 4.3 ACCEPTED* 
  
 
Statistical evaluation for cloxacillin in material M-B after adjustment to pH=6 
Date of storage 
at -80 °C 
Time at -20°C 
(days) 
Average amount  
(µg/kg) 
n Pooled st. dev 
(µg/kg) 
t tcrit t < tcrit 
Nov 23, 2006 0 149 2     
Feb 07, 2007 76 148 2 10.5 0.10 4.3 ACCEPTED 
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* Accepted due to the low amount of data. The difference between the amount on t=0 and t=76 is >25%. 
Therefore the material without treatment can not be characterized as stable. 
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Annex 3c Statistical evaluation of stability data of material K-B for 
ampicillin  
 
 
Statistical evaluation for ampicillin in material K-B without treatment 
Date of storage 
at -80 °C 
Time at -20°C 
(days) 
Average amount  
(µg/kg) 
n Pooled st. dev 
(µg/kg) 
t tcrit t < tcrit 
Nov 11, 2007 0 39.9 2     
Feb 07, 2007 88 1.9 2 3.78 10.0 4.3 NOT ACCEPTED 
  
 
Statistical evaluation for ampicillin in material K-B after adjustment to pH=6 
Date of storage 
at -80 °C 
Time at -20°C 
(days) 
Average amount  
(µg/kg) 
n Pooled st. dev 
(µg/kg) 
t tcrit t < tcrit 
Nov 11, 2007 0 44.3 2     
Feb 07, 2007 88 23.4 2 2.34 8.9 4.3 NOT ACCEPTED 
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Annex 3d Statistical evaluation of stability data of material K-B for 
cloxacillin  
 
 
Statistical evaluation for cloxacillin in material K-B without treatment 
Date of storage 
at -80 °C 
Time at -20°C 
(days) 
Average amount  
(µg/kg) 
n Pooled st. dev 
(µg/kg) 
t tcrit t < tcrit 
Nov 11, 2007 0 103 2     
Feb 07, 2007 88 26 2 3.97 19 4.3 NOT ACCEPTED 
  
 
Statistical evaluation for cloxacillin in material K-B after adjustment to pH=6 
Date of storage 
at -80 °C 
Time at -20°C 
(days) 
Average amount  
(µg/kg) 
n Pooled st. dev 
(µg/kg) 
t tcrit t < tcrit 
Nov 11, 2007 0 107 2     
Feb 07, 2007 88 84 2 5.1 4.5 4.3 NOT ACCEPTED 
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Annex 3e Statistical evaluation of stability data of material K-B for  
penicillin G  
 
 
Statistical evaluation for penicillin G in material K-B without treatment 
Date of storage 
at -80 °C 
Time at -20°C 
(days) 
Average amount  
(µg/kg) 
n Pooled st. dev 
(µg/kg) 
t tcrit t < tcrit 
Nov 11, 2007 0 23.5 2     
Feb 07, 2007 88 5.8 2 0.87 20.3 4.3 NOT ACCEPTED 
  
 
Statistical evaluation for penicillin G in material K-B after adjustment to pH=6 
Date of storage 
at -80 °C 
Time at -20°C 
(days) 
Average amount  
(µg/kg) 
n Pooled st. dev 
(µg/kg) 
t tcrit t < tcrit 
Nov 11, 2007 0 26.0 2     
Feb 07, 2007 88 17.4 2 1.13 7.62 4.3 NOT ACCEPTED 
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Annex 4 Overview of the applied methods 
 
Lab 
code 
Stabilization / 
storage 
Extraction Sample purification Derivatization Internal standard Detection 
method 
Penicillins not 
analysed for 
3 -70 °C Phosphate buffer 
(pH=8), hexane 
SPE (C18), elution with H2O/ACN 
(1:1) 
- - LC-MS/MS - 
4 -18 °C Phosphate buffer, hexane SPE (C18), elution with H2O/ACN 
(1:1) 
- 13C2-Pen G LC-MS/MS - 
5 -70 °C Phosphate buffer 
(pH=8), iso-octane 
SPE (C18), elution with Phosphate 
buffer/ACN (1:1), derivatization 
Benzoic acid 
anhydride, triazole, 
HgCl2, pH=9, 10 min, 
65 °C 
- LC-DAD - 
6 -80°C H2O/ACN (1:9), 
evaporation of solvent, 
add phosphate buffer 
(pH=8.5) 
SPE (OASIS HLB), elution with 
ACN/H2O (7:3), partial 
evaporation of solvent 
- - LC-MS/MS - 
7 -18°C ACN/H2O (4:1) RP18, evaporation of solvent, filter 
0.45 µm 
- - LC-MS/MS - 
8 -70 °C Phosphate buffer 
(pH=9), hexane 
SPE (C18), elution with MeOH, 
partial evaporation of solvent 
- - LC-MS/MS - 
9 -20 °C ACN/acetone (7:3) Evaporation of solvent, 
reconstitution, ultrafiltration (30 
kD) 
- sulfamethazin LC-MS/MS - 
10 -80 °C Screening: DSM 
Confirmatory: ACN 
Evaporation of solvent, 
reconstitution 
- Pen V LC-MS/MS Pen V 
11 -80 °C ACN Evaporation of solvent, 
reconstitution, filter 0.45 µm 
- Pen V LC-MS/MS  
13 -89 °C Phosphate buffer 
(pH=8.5), ios-octane 
SPE (C18), elution with ACN/H2O 
(1:1) 
- - LC-MS/MS - 
14 -80 °C Screening: Ec 6-plate 
test 
- - - Plate test - 
15 Buffer pH=6,  -
80 °C 
Phosphate buffer 
(pH=8), derivatization 
SPE (OASIS HLB), elution with 
H2O/methanol (1:4), evaporation 
of solvent, reconstitution 
Piperidin, phosphoric 
acid, 5 min, 85 °C 
Piperidinpenicillins-d10 LC-MS/MS - 
16 -20 °C ACN, petrolium ether Partial evaporation of solvent, 
freezing, microfiltration 
- methicillin LC-MS/MS - 
17 -80 °C ACN Kidney: none 
Muscle: SPE (OASIS HLB) 
- nafcillin LC-MS/MS Amoxycillin, 
Oxacillin 
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18 -85 °C Phosphate buffer 
(pH=8.2) 
SPE (OASIS HLB), elution with 
MeOH, evaporation of solvent, 
reconstitution 
- - UPLC-
MS/MS 
- 
19 -70 °C Phosphate buffer 
(pH=8), hexane 
SPE (C18), elution ACN, 
evaporation of solvent, 
reconstitution  
- Pen V LC-MS/MS Pen V 
20 -80 °C Muscle: Phosphate 
buffer 
Kidney: sulphuric acid, 
sodium wolframate 
SPE (C18) - Pen V LC-MS/MS - 
21 -70 °C  Methanol/H2O (85:15), 
dilution 
SPE (C18) - - LC-MS/MS Cloxacillin, 
Dicloxacillin, 
Oxacillin, Pen V 
NM = not mentioned 
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Annex 5 Overview of method characteristics as reported by the participants  
 
 Muscle Kidney 
  Ampicillin Cloxacillin  Ampicillin Cloxacillin Penicillin G 
Lab 
code 
Validation / 
accreditation 
CCα 
(µg/kg) 
CCß 
(µg/kg) 
CCα 
(µg/kg) 
CCß 
(µg/kg) 
Validation / 
accreditation 
CCα 
(µg/kg) 
CCß 
(µg/kg) 
CCα 
(µg/kg) 
CCß 
(µg/kg) 
CCα 
(µg/kg) 
CCß 
(µg/kg) 
3 No / Yes  50  300 No / Yes  50  300  50 
4 Yes / Yes     Yes / Yes       
5 Yes / Yes 72 82 310 326 No / No       
6 No / No     No / No       
7 Yes / Yes     Yes / Yes       
8 Yes / Yes 62 74 357 416 Yes / Yes 62 74 386 473 60 70 
9 No / Yes     No / Yes       
10 On going / No     On going / No       
11 On going / No 53 56.1 320.4 340.8 On going / No 57.8 65.6 365.0 429.9 65.0 80.0 
13 Yes / Yes     Yes / Yes       
14             
15 Yes / Yes 56 62 324 353 Yes / Yes 55 59 349 379 58 63 
16 On going / Yes     On going / Yes       
17 No / No     No / No       
18 No / No     No / No       
19 Yes / Yes 54.9 59.8 324.3 348.5 Yes / Yes 54.9 59.8 324.3 348.5 35.6 57.2 
20 No / No     No / No       
21 Yes / Yes  < 50  < 300 Yes / Yes  < 50  < 300 58 67 
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 Muscle Kidney 
  Ampicillin Cloxacillin  Ampicillin Cloxacillin Penicillin G 
Lab 
code 
Validation / 
accreditation 
LoD 
(µg/kg) 
LoQ 
(µg/kg) 
LoD 
(µg/kg) 
LoQ 
(µg/kg) 
Validation / 
accreditation 
LoD 
(µg/kg) 
LoQ 
(µg/kg) 
LoD 
(µg/kg) 
LoQ 
(µg/kg) 
LoD 
(µg/kg) 
LoQ 
(µg/kg) 
3 No / Yes 0.5 1.0 2.0 4.0 No / Yes 0.5 1.0 2.0 4.0 0.5 1.0 
4 Yes / Yes 2 5 5 10 Yes / Yes 2 5 5 10 2 5 
5 Yes / Yes 6 21 10 32 No / No       
6 No / No 2 10 5 10 No / No 2 10 5 10 5 15 
7 Yes / Yes 1.3 7.5 1.3 7.5 Yes / Yes 5.0 19 3.0 11 2.0 8.0 
8 Yes / Yes     Yes / Yes       
9 No / Yes 1 1.5 1 1.5 No / Yes 1 1.5 1 1.5 1 1.5 
10 On going / No  25  150 On going / No  25  150  25 
11 On going / No <1 25 ~2 150 On going / No 2 25 ~2 150 ~2 25 
13 Yes / Yes 5 10 5 10 Yes / Yes 5 10 5 10 5 10 
14             
15 Yes / Yes 5  15  Yes / Yes 5  15  5  
16 On going / Yes 0.5 0.5 0.5 0.5 On going / Yes 0.5 0.5 0.5 0.5 0.5 0.5 
17 No / No  5  5 No / No  5  5  5 
18 No / No     No / No       
19 Yes / Yes  25  150 Yes / Yes  25  150  25 
20 No / No     No / No       
21 Yes / Yes     Yes / Yes     3.4 10 
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Annex 6a Results for the analysis of ampicillin in muscle (material M-B) 
 
Ampicillin 
Assigned value: 3.4 µg/kg 
Uncertainty of assigned value: 0.5 µg/kg 
Target standard deviation (Horwitz, Thompson): 0.75 µg/kg 
Code Replicate 1 Replicate 2 Replicate 3 Replicate 4 Average  sr LRs  za’-score 
HORRAT 
2          
3 2.8 3.2 3.7 1.9 2.9 0.75 0.75 -0.58 1.00 
4 3.5 2.9 4.5 4.7 3.9 0.26 1.01 0.52 1.33 
5               
6  <10 <10  <10   <10       
7 1.6 1.6 2.0 2.0 1.8 0.00 0.28 -1.80 0.37 
8 <25 <25  <25  <25        
9 3.3 3.4 2.9 2.8 3.1 0.06 0.34 -0.39 0.45 
10 7.1 7.9 6.4 8.2 7.4 0.80 0.80 4.38 1.07 
11 5.1 4.4 5.0 5.1 4.9 0.29 0.29 1.62 0.39 
12          
13 14.0 15.0 12.0 14.0 13.8 0.91 1.24 11.40 1.65 
14               
15 <12.5 <12.5  <12.5  <12.5        
16 1.8 2.1 2.1 2.1 2.0 0.11 0.16 -1.56 0.21 
17               
18               
19 <25 <25  <25  <25        
20 1.7 2.8 1.0 2.3 2.0 0.70 0.70 -1.63 0.92 
21 2.5 2.9 3.7 3.1 3.1 0.29 0.54 -0.42 0.71 
Results are for information only.
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Annex 6a Results for the analysis of ampicillin in muscle (material M-B) 
(continued) 
 
Figure a: Graphical representation of the reported results 
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Annex 6b Results for the analysis of cloxacillin in muscle (material M-B) 
 
Cloxacillin 
Assigned value: 135 µg/kg 
Uncertainty of assigned value: 9.5 µg/kg 
Target standard deviation (Horwitz, Thompson): 29.2 µg/kg 
Code Replicate 1 Replicate 2 Replicate 3 Replicate 4 Average  sr LRs za’-score 
HORRAT 
2              
3 142.0 159.0 110.0 118.0 132.3 7.67 7.67 -0.10 0.90 
4 351.0 341.0 390.0 338.0 355.0 21.62 21.62 7.15 0.74 
5 136.1 141.7 120.3 123.2 130.3 2.57 2.57 -0.16 0.42 
6 126.5 127.2 118.2 120.7 123.2 1.06 1.06 -0.39 0.18 
7 102.0 105.0 119.0 112.0 109.5 3.11 3.11 -0.84 0.30 
8 201.0 205.0 165.0 191.0 190.5 10.74 10.74 1.80 0.66 
9 135.0 127.0 121.0 118.0 125.3 3.49 3.49 -0.33 0.29 
10 148.9 166.3 111.5 121.2 137.0 8.13 8.13 0.06 1.02 
11 176.0 158.0 188.0 167.0 172.3 11.29 11.29 1.20 0.39 
12              
13 160.0 170.0 230.0 240.0 200.0 5.77 5.77 2.11 1.70 
14              
15 126.0 138.0 136.0   133.3 55.74 55.74 -0.06  
16 84.3 79.2 92.1 80.5 84.0 5.17 5.17 -1.67 0.18 
17 80.0 81.0 100.0 99.0 90.0 0.58 0.58 -1.47 0.46 
18 72.6 80.2 129.9 141.0 105.9 5.49 5.49 -0.96 1.43 
19 <150 <150  <150  <150  <150     
20 161.8 144.5 121.4 143.6 142.8 11.49 11.49 0.25 0.57 
21              
Results are for information only
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Annex 6b Results for the analysis of cloxacillin in muscle (material M-B) 
(continued) 
 
Figure a: Graphical representation of the reported results 
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Figure b: Graphical representation of za’-score             Figure c: Graphical representation of HORRAT  
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Annex 6c Results for the analysis of ampicillin in kidney (material K-B) 
 
Ampicillin 
Assigned value: 9.1 µg/kg 
Uncertainty of assigned value: 2.5 µg/kg 
Target standard deviation (Horwitz, Thompson): 2.0 µg/kg 
Code Replicate 1 Replicate 2 Replicate 3 Replicate 4 Average  sr LRs
 
2            
3     0.8 1.2    
4 11.0 10.0 10.0 14.0 11.3 1.68 1.68 
5            
6 <10 <10  <10  <10     
7            
8 <25 <25 <25  <25     
9 2.3 2.2 1.8 2.0 2.1 0.08 0.29 
10 16.8 9.7 21.9   16.1 9.40 9.40 
11 3.9 4.7 8.6 6.2 5.9 1.03 2.31 
12            
13 17.0 19.0 21.0 23.0 20.0 1.15 2.94 
14            
15 <12.5 13.2 <12.5  <12.5  13.2   
16 1.9 1.8 1.1 1.5 1.6 0.13 0.41 
17            
18            
19 <25 <25  <25  <25     
20 5.3 5.1 7.3 5.6 5.8 0.70 1.01 
21 12.4 10.6 13.0 10.4 11.6 1.29 1.29 
Results are for information only 
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Annex 6c Results for the analysis of ampicillin in kidney (material K-B) 
(continued) 
 
Figure a: Graphical representation of the reported results 
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Annex 6d Results for the analysis of cloxacillin in kidney (material K-B) 
 
Cloxacillin 
Assigned value: 31.3 µg/kg 
Uncertainty of assigned value: 5.2 µg/kg 
Target standard deviation (Horwitz, Thompson): 6.9 µg/kg 
Code Replicate 1 Replicate 2 Replicate 3 Replicate 4 Average  sr LRs
2            
3 26.4 17.9 22.6 15.8 20.7 4.44 4.44 
4 86.0 83.0 86.0 83.0 84.5 1.73 1.73 
5            
6 29.2 28.2 25.5 22.3 26.3 1.37 3.53 
7 18.0 19.0 18.0 21.0 19.0 1.29 1.29 
8 <150 <150  <150  <150     
9 18.6 14.3 9.9 12.9 13.9 2.15 3.89 
10 57.6 65.2 66.8   63.2 27.45 27.45 
11 26.4 29.2 41.7 37.6 33.7 2.03 8.50 
12            
13 <10 <10  24.0 25.0    
14            
15 47.0 <30 <30  <30  47.0   
16 17.5 16.8 11.6 15.6 15.4 1.66 2.77 
17 22.0 22.0 17.0 17.0 19.5 0.00 3.54 
18            
19 <150 <150  <150  <150     
20 46.9 46.4 66.6 53.8 53.4 5.23 10.27 
21        
Results are for information only 
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Annex 6d Results for the analysis of cloxacillin in kidney (material K-B) (continued) 
 
Figure a: Graphical representation of the reported results 
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Annex 6e Results for the analysis of penicillin G in kidney (material K-B) 
 
Penicillin G 
Assigned value: 13.7 µg/kg 
Uncertainty of assigned value: 3.2 µg/kg 
Target standard deviation (Horwitz, Thompson): 3.0 µg/kg 
Code Replicate 1 Replicate 2 Replicate 3 Replicate 4 Average  sr LRs
2            
3 4.3 4.0 3.3 4.8 4.1 0.62 0.62 
4 24.0 29.0 28.0 24.0 26.3 2.61 2.61 
5            
6 <15 <15  <15  <15  <15   
7 12.0 13.0 13.5 14.0 13.1 0.46 0.94 
8            
9 5.7 4.6 3.6 4.5 4.6 0.54 0.87 
10 28.4 26.5 35.2   30.0 14.39 14.39 
11 19.8 22.6 26.4 25.0 23.5 1.28 3.31 
12            
13 <10 <10  <10  <10     
14            
15     15.7 16.0    
16 5.7 5.5 4.0 5.3 5.1 0.57 0.78 
17 10.0 9.0 8.0 8.0 8.8 0.41 1.10 
18            
19 <25 <25  <25  <25     
20 12.1 11.2 14.4 11.3 12.3 1.32 1.32 
21 11.2 11.0 12.9 12.5 11.9 0.18 1.14 
Results are for information only 
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Annex 6e 
Results for the analysis of penicillin G in kidney (material K-B) (continued) 
 
Figure a: Graphical representation of the reported results 
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Annex 7 
Storage temperature versus laboratory results for cloxacillin in muscle 
(material M-B) 
 
Cloxacillin 
Assigned value: 31.3 µg/kg 
Code Storage temperature (°C) Average result (µg/kg) 
2    
3 -70 132.3 
4 -18 355.0 
5 -70 130.3 
6 -80 123.2 
7 -18 109.5 
8 -70 190.5 
9 -20 125.3 
10 -80 137.0 
11 -80 172.3 
12    
13 -89 200.0 
14    
15 -70 133.3 
16 -20 84.0 
17 -80 90.0 
18 -85 105.9 
19    
20 -80 142.8 
21    
 
Figure a: Graphical representation of the average result versus the storage temperature 
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Annex 8 
Date of analysis versus laboratory results for cloxacillin in muscle (material 
M-B) 
 
Cloxacillin 
Assigned value: 31.3 µg/kg 
Code Date of analysis Average result (µg/kg) 
2    
3 19 January 2007 132.3 
4 19 December 2006 355.0 
5 09 January 2007 130.3 
6 22 January 2007 123.2 
7 19 January 2007 109.5 
8 31 January 2007 190.5 
9 19 January 2007 125.3 
10 10 January 2007 137.0 
11 22 January 2007 172.3 
12    
13 29 January 2007 200.0 
14    
15 11 January 2007 133.3 
16 11 January 2007 84.0 
17 25 January 2007 90.0 
18 09 January 2007 105.9 
19    
20 04 January 2007 142.8 
21    
 
Figure a: Graphical representation of the average result versus the date of analysis 
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